2-Nitrobenzylbromide structure
|
Common Name | 2-Nitrobenzylbromide | ||
|---|---|---|---|---|
| CAS Number | 3958-60-9 | Molecular Weight | 216.032 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | 275.2±15.0 °C at 760 mmHg | |
| Molecular Formula | C7H6BrNO2 | Melting Point | 44-46 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 120.2±20.4 °C | |
| Symbol |
GHS05 |
Signal Word | Danger | |
| Name | 2-Nitrobenzyl bromide |
|---|---|
| Synonym | More Synonyms |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 275.2±15.0 °C at 760 mmHg |
| Melting Point | 44-46 °C(lit.) |
| Molecular Formula | C7H6BrNO2 |
| Molecular Weight | 216.032 |
| Flash Point | 120.2±20.4 °C |
| Exact Mass | 214.958176 |
| PSA | 45.82000 |
| LogP | 2.65 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.612 |
| InChIKey | HXBMIQJOSHZCFX-UHFFFAOYSA-N |
| SMILES | O=[N+]([O-])c1ccccc1CBr |
| Storage condition | 2-8°C |
| Water Solubility | insoluble |
| Symbol |
GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | C:Corrosive; |
| Risk Phrases | R34 |
| Safety Phrases | S26-S36/37/39-S45 |
| RIDADR | UN 3261 8/PG 2 |
| WGK Germany | 3 |
| Packaging Group | II |
| Hazard Class | 8 |
| HS Code | 29049085 |
| Precursor 8 | |
|---|---|
| DownStream 10 | |
| HS Code | 2904909090 |
|---|---|
| Summary | HS:2904909090 sulphonated, nitrated or nitrosated derivatives of hydrocarbons, whether or not halogenated VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
|
Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction.
J. Comb. Chem. 11 , 14-33, (2009) Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa... |
|
|
A photolabile hydrogel for guided three-dimensional cell growth and migration.
Nat. Mater. 3(4) , 249-53, (2004) Tissue engineering aims to replace, repair or regenerate tissue/organ function, by delivering signalling molecules and cells on a three-dimensional (3D) biomaterials scaffold that supports cell infilt... |
|
|
Caged cysteine and thiophosphoryl peptides.
FEBS Lett. 405(1) , 81-5, (1997) Photoreleasable molecules are important in studies of various biological phenomena, especially cell signaling. Here we report a generally applicable approach for 'caging' unprotected cysteine-containi... |
| 1-(Bromomethyl)-2-nitrobenzene |
| o-nitrobenzyl bromide |
| nitrobenzyl bromide |
| MFCD00007184 |
| EINECS 223-558-9 |
| Benzene, 1-(bromomethyl)-2-nitro- |
| α-Bromo-2-nitrotoluene |
| 2-Nitrobenzylbromide |